These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17115310

  • 1. Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery.
    Gullichsen R.
    Tech Coloproctol; 2006 Dec; 10(4):346-9. PubMed ID: 17115310
    [Abstract] [Full Text] [Related]

  • 2. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
    Van Assche G, Ferrante M, Vermeire S, Noman M, Rans K, Van der Biest L, Penninckx F, Wolthuis A, Rutgeerts P, D'Hoore A.
    Colorectal Dis; 2012 Apr; 14(4):e181-6. PubMed ID: 21951549
    [Abstract] [Full Text] [Related]

  • 3. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
    Mystakidou K, Katsouda E, Tsilika E, Smyrniotis V, Vassiliou I, Tsiatas M, Vlahos L.
    Anticancer Res; 2006 Apr; 26(3B):2325-8. PubMed ID: 16821610
    [Abstract] [Full Text] [Related]

  • 4. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Apr; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 5. Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy.
    Nilubol N, Scherl E, Bub DS, Gorfine SR, Marion J, Harris MT, Kornbluth A, Lichtiger S, Rubin P, George J, Chapman M, Harpaz N, Present D, Bauer JJ.
    Dis Colon Rectum; 2007 Jun; 50(6):825-31. PubMed ID: 17429711
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 7. Octreotide in the management of diarrhea induced by graft versus host disease.
    Ippoliti C, Neumann J.
    Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
    [Abstract] [Full Text] [Related]

  • 8. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 9. Portal vein thrombi after restorative proctocolectomy: serious complication without long-term sequelae.
    Millan M, Hull TL, Hammel J, Remzi F.
    Dis Colon Rectum; 2007 Oct; 50(10):1540-4. PubMed ID: 17701370
    [Abstract] [Full Text] [Related]

  • 10. Parking the pouch: pouch salvage after anastomotic leak following restorative proctocolectomy. Report of a case.
    Maruthachalam K, Kumar R, Hainsworth P.
    Dis Colon Rectum; 2008 Nov; 51(11):1724-6. PubMed ID: 18484132
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C, Vecht J, Masclee AA.
    Aliment Pharmacol Ther; 2005 Nov 15; 22(10):963-9. PubMed ID: 16268971
    [Abstract] [Full Text] [Related]

  • 12. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S.
    Support Care Cancer; 2004 Aug 15; 12(8):561-70. PubMed ID: 15160318
    [Abstract] [Full Text] [Related]

  • 13. An open trial of octreotide long-acting release in the management of short bowel syndrome.
    Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG.
    Am J Gastroenterol; 2001 May 15; 96(5):1494-8. PubMed ID: 11374688
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
    Morton AJ, Durrant ST.
    Clin Transplant; 1995 Jun 15; 9(3 Pt 1):205-8. PubMed ID: 7549062
    [Abstract] [Full Text] [Related]

  • 15. What are the outcomes of reoperative restorative proctocolectomy and ileal pouch-anal anastomosis surgery?
    Shawki S, Belizon A, Person B, Weiss EG, Sands DR, Wexner SD.
    Dis Colon Rectum; 2009 May 15; 52(5):884-90. PubMed ID: 19502852
    [Abstract] [Full Text] [Related]

  • 16. [Restorative proctocolectomy with an ileoanal pouch. Postoperative course and long-term functional results].
    Walker LR, Bülow S.
    Ugeskr Laeger; 2008 May 12; 170(20):1721-5. PubMed ID: 18489884
    [Abstract] [Full Text] [Related]

  • 17. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery.
    Hait EJ, Bousvaros A, Schuman M, Shamberger RC, Lillehei CW.
    J Pediatr Surg; 2007 Jan 12; 42(1):31-4; discussion 34-5. PubMed ID: 17208537
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
    Walker JJ, Kaplan DS.
    Am J Gastroenterol; 1993 May 12; 88(5):765-7. PubMed ID: 8480746
    [Abstract] [Full Text] [Related]

  • 19. Outcome of pouch surgery for ulcerative colitis: single center experience.
    El-Raouf AA, Hak NG, Fathy O, El-Ebidy G, Salah T, El-Hemaly M.
    Hepatogastroenterology; 2008 May 12; 55(88):2130-4. PubMed ID: 19260491
    [Abstract] [Full Text] [Related]

  • 20. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue.
    Murao S, Hirata K, Ishida T, Takahara J.
    Endocr J; 1999 Jun 12; 46(3):477-8. PubMed ID: 10504003
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.